Femme Homme
- | Pays :
- Serbia
- | Organes : -
- | Spécialités : -
Extrait
This is a Phase II study designed to evaluate whether the co-administration of a fixed dose of tesmilifene and a standard regimen of docetaxel alters the plasma pharmacokinetics of docetaxel. This study will also assess the safety and efficacy of the tesmilifene/docetaxel combination in metastatic breast cancer patients.
Critère d'inclusion
- Metastatic breast cancer